二甲双胍
2019年冠状病毒病(COVID-19)
医学
肺
黄芩苷
肾
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
药理学
内科学
化学
病理
内分泌学
糖尿病
疾病
高效液相色谱法
色谱法
爆发
传染病(医学专业)
作者
Verónica Miguel,C. Rey,Jessica Tituaña,Belén Sirera,Elena Alcalde‐Estévez,J. Ignacio Herrero,Irene Ranz,L. Fernández,Carolina Castillo,L. F. Vega Sevilla,James S. Nagai,Katharina C. Reimer,Jitske Jansen,Rafael Kramann,Ivan G. Costa,Ana Castro,David Sancho,José Miguel Rodríguez González-Moro,Santiago Lamas
出处
期刊:Redox biology
[Elsevier]
日期:2023-11-03
卷期号:68: 102957-102957
被引量:11
标识
DOI:10.1016/j.redox.2023.102957
摘要
Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (COVID-19) pandemic. It is the final outcome of the acute respiratory distress syndrome (ARDS), characterized by an initial exacerbated inflammatory response, metabolic derangement and ultimate tissue scarring. A positive balance of cellular energy may result crucial for the recovery of clinical COVID-19. Hence, we asked if two key pathways involved in cellular energy generation, AMP-activated protein kinase (AMPK)/acetyl-CoA carboxylase (ACC) signaling and fatty acid oxidation (FAO) could be beneficial. We tested the drugs metformin (AMPK activator) and baicalin (CPT1A activator) in different experimental models mimicking COVID-19 associated inflammation in lung and kidney. We also studied two different cohorts of COVID-19 patients that had been previously treated with metformin. These drugs ameliorated lung damage in an ARDS animal model, while activation of AMPK/ACC signaling increased mitochondrial function and decreased TGF-β-induced fibrosis, apoptosis and inflammation markers in lung epithelial cells. Similar results were observed with two indole derivatives, IND6 and IND8 with AMPK activating capacity. Consistently, a reduced time of hospitalization and need of intensive care was observed in COVID-19 patients previously exposed to metformin. Baicalin also mitigated the activation of pro-inflammatory bone marrow-derived macrophages (BMDMs) and reduced kidney fibrosis in two animal models of kidney injury, another key target of COVID-19. In human epithelial lung and kidney cells, both drugs improved mitochondrial function and prevented TGF-β-induced renal epithelial cell dedifferentiation. Our results support that favoring cellular energy production through enhanced FAO may prove useful in the prevention of COVID-19-induced lung and renal damage.
科研通智能强力驱动
Strongly Powered by AbleSci AI